Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 3

Clopidogrel inhibits acetylcholine-induced contractions of urinary bladder in rat

Pages
459–463
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The statistical analyses of the data were made in the SPSS 22.0 program by applying Paired T-Test.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Clopidogrel as thrombocyte Adenosine Diphosphate (ADP) receptor antagonist is used especially in peripheric artery diseases by lengthening hemorrhage time, disrupting thrombocyte aggregation and decreasing blood viscosity.
📊
Key Findings & Data:This study was conducted to investigate the effects of Clopidogrel on bladder contraction-relaxation mechanism.Material and Methods: In the present study, the bladder tissues taken from Wistar-Albino (n=7) intact female rats were used.
💡
Conclusion & Impact:The statistical analyses of the data were made in the SPSS 22.0 program by applying Paired T-Test.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Clopidogrel as thrombocyte Adenosine Diphosphate (ADP) receptor antagonist is used especially in peripheric artery diseases by lengthening hemorrhage time, disrupting thrombocyte aggregation and decreasing blood viscosity. It shows its antagonist effects through glycoprotein (Gp) IIb/IIIa complex ADP by preventing its activation. Although the usage area and activity is in the vascular system, there are no adequate studies showing the activity of Clopidogrel on smooth muscle contraction-relaxation mechanism. This study was conducted to investigate the effects of Clopidogrel on bladder contraction-relaxation mechanism.Material and Methods: In the present study, the bladder tissues taken from Wistar-Albino (n=7) intact female rats were used. After the decapitation, the longitudinal bladder tissues that were received 1-mm-thick, 8-mm length, and 2-mm-width, were hung in the 5-ml isolated organ bath that had Krebs-Ringer bicarbonate solution by applying 1.5 gr strain. After the bladder contractions were induced with 10 μM dose Acetylcholine (Ach), Clopidogrel was applied as two doses 0.1μM and 10μM in a noncumulative manner. The peak-to-peak (p-p) values and the values below the curve before and after the Clopidogrel application in the contraction induced with Ach were normalized as % change. The statistical analyses of the data were made in the SPSS 22.0 program by applying Paired T-Test. The p

🔖

Cite This Article

SERHATLIOĞLU, İ., KAÇAR, E. (2022). Clopidogrel inhibits acetylcholine-induced contractions of urinary bladder in rat. Annals of Medical Research, Cilt: 26 - Sayı: 3, 459–463. https://ajindex.com/articles/446906

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Coyne KS, Sexton CC, Thompson, CL, et al. The prevalence of lower urinary tract symptoms (LUTS) in the U. S. A., the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int 2009;104:352-60
  2. Ford AP, Cockayne DA. ATP and P2X purinoceptors in urinary tract disorders. Handb Exp Pharmacol 2011;202:485-526
  3. Liu G, Daneshgari F. Alterations in neurogenically mediated contractile responses of urinary bladder in rats with diabetes. Am J Physiol Renal Physiol 2005;288:1220-6
  4. Burnstock G. Introductory overview of purinergic signalling. Front Biosci 2011;3:896-900
  5. Aronsson P, Andersson M, Ericsson T, et al. Assessment and characterization of purinergic contractions and relaxations in the rat urinary bladder. Basic Clin. Pharmacol Toxicol 2010;107:603-13
  6. McMurray G, Dass N, Brading AF. Purinoceptor subtypes mediating contraction and relaxation of marmoset urinary bladder smooth muscle. Br J Pharmacol 1998;123:1579-86
  7. Suzuki H, Kokubun S. Subtypes of purinoceptors in rat and dog urinary bladder smooth muscles. Br J Pharmacol 1994;112:117-22
  8. Schror K. Antiplatelet drugs: a comparative review. Drugs 1995;50:7-28
  9. Lau WC, Waskell LA, Watkins PB, et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation 2003;107:32-7
  10. Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004;113: 340-5
  11. Herbert JM, Tissiner A, Defreyn G, et al. Inhibitory effect of clopidogrel on platelet adhesion and intimal profileration after arterial injury in rabbits. Arterioscler Thromb 1993;13:1171-9
  12. Chen Z, Jiang L, Chen Y, et al. COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomised placebo controlled trial. Lancet 2005;366:1607-21
  13. Yusuf S, Bijsterveld N, Moons A. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation: the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. N Engl J Med 2001;345:494-502
  14. Kunapuli SP, Dorsam RT, Kim S, et al. Platelet purinergic receptors. Curr. Opin. Pharmacol 2003;3:175-80
  15. Beavers CJ, Naqvi IA. Clopidogrel.SourceStatPearls [Internet]. Treasure Island (FL): StatPearls Publishing 2018
  16. Pultar J, Wadowski PP, Panzer S, et al. Oral antiplatelet agents i